Possible Benefits of Paclitaxel Therapy for COVID-19

Abstract

The coronavirus disease 2019 (COVID-19) was reported in Wuhan, China, in late December 2019 and soon became the most serious global health challenge due to the high rate of human-to-human transmission. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus and belongs to the large Coronaviridae family [1].

Keywords

• covid-19
• paclitaxel
• anti-inflammatory
• antiviral activity